ArticleNature cancer2025
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma.
Weiqiang Jing et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papercites it